January 22, 2007

Below are excerpts from two timely articles that offer persuasive arguments backed by evidence demonstrating that litigation

Read More
Role of Litigation in Defining Drug Risks_JAMA / BMJ

January 6, 2007

 The latest example of corruption at the NEJM was reported by The Wall StreetJournal (below).  The NEJM

Read More
NEJM- Caught Covering Up for National Kidney Foundation–an indudstry front group

December 4, 2006

I posted to the IRB Forum (a chatroom) the AHRP Infomail reporting about the Harvard study of

Read More
IRB Forum Not Inclined to Discuss the Most Serious Issue of All

November 29, 2006

Those who approve research protocols, ethics committees–called, institutional review boards, IRB–are riddled with conflicts of interest.   In

Read More
Hospital IRBs are “On the Take”–Tainted by Conflicts ofInterest_NEJM

November 23, 2006

The drug industry's undue influence–on the FDA and its advisory committees that are made up mostly of

Read More
Dangerous Deception: Hiding the Evidence of Adverse Drug Effects_NEJM

November 4, 2006

A prescription drug’s success is measured by the size of the population in which it is used. 

Read More
Potent Narcotic ‘Lollipop’ Becomes Best Seller_WSJ

October 31, 2006

The Los Angeles Times reports (below) about the latest study in "a welter of efforts to identify

Read More
NIMH Chief Child/Adoles Research Blows Wind out TeenScreen Sails_ Los Angeles Times

October 26, 2006

“The scariest thing is that nobody knows” risks of depression drugs for children Mon, 10 May 2004

Read More
"The scariest thing is that nobody knows" risks of depression drugs for children

October 26, 2006

July 12, 2002 Babies Exposed to Toxic Vaccines FYI Several recent articles focus on unsafe vaccines: ABC

Read More
FDA MedWatch data show olanzapine (Zyprexa) -diabetes risk

October 26, 2006

To view AHRP news and infomails from 2006, please visit our new site. Infomails Subscribe to AHRP’s

Read More
What’s New? – Alliance for Human Research Protection

October 26, 2006

AHRP Speaks Out AHRP Press Briefing 9/14/04: Antidepressants & suicide-related risks for children Open Letter to NIMH

Read More
Featured News

October 26, 2006

From: “VERACARE” To: “Dr. Bart Campbell” Subject: RE: AHRP Response to criticism re: fatal ARDS lung experiment

Read More
Article

October 26, 2006

FDA: regulatory protections for children. Comments submitted by Vera Hassner Sharav, John H. Noble, Jr., Ph.D and

Read More
FDA: Regulatory Protections for Children. Comments by Sharav, Noble, & Fishman for AHRP

October 26, 2006

Public Comments: Dr. William J. Bicknell, Professor of International Health, Boston University Dear Dr. Ball: I am

Read More
Public Comments Dr. William J. Bicknell Prof. Int’l Health, Boston U